Although lipid-lowering therapy has led to some improvement, atherosclerosis still accounts for a significant number of deaths due to cardiovascular disease, underscoring the urgent need for identifying new potential target genes in clinical practice. Macrophages possess remarkable plasticity and a multitude of biological functions, which has prompted scientists to study their relationship with atherosclerosis for over 50 years, and significant discoveries are still being made today[5]. Recent advances in single-cell RNA sequencing technology have allowed scientists to uncover the remarkable diversity of macrophage populations within atherosclerotic plaques[27-30]. These subpopulations exhibit distinct gene expression and functional characteristics, and they play critical roles in the initiation, progression, stabilization, regression, and rupture of atherosclerotic plaques[31, 32]. Therefore, it is essential to systematically explore the expression profile of macrophage-related genes and identify key genes to gain a profound understanding of the pathological features of atherosclerosis. In this study, we constructed a model composed of five macrophage-related genes (STAB1, NLRP3, IL1RN, HMOX1 and DAB2) based on multiple omics data, which showed highly accurate diagnostic performance. This may facilitate the progress of molecular diagnosis and immune-regulatory treatment of atherosclerosis.
STAB1 as a conserved scavenger receptor, it binds and uptakes LDL. However, a study has shown that the sole expression of Stab1 in macrophages is not sufficient to affect aortic atherosclerosis, and only Ldlr-KO mice with Stab1 deficiency limited to the hematopoietic system do not display changes in plaque development[33]. In a recent study, it was found that mice with Stab1 knocked out throughout the body can significantly inhibit atherosclerosis. The mechanism is that after Stab1 knockout, the altered plasma proteome suppresses both patrolling and inflammatory monocytes, and thus systemically protects against atherogenesis[34].
NLRP3 inflammasome, an inflammatory multiprotein complex, plays a pivotal role in the pathogenesis of atherosclerosis. Within the complex process of atherosclerosis, the activation of endothelial cells, macrophages, T lymphocytes and other cells leads to the secretion of pro-inflammatory cytokines, which in turn triggers inflammation reactions and further intensifies the progress of atherosclerosis[35]. As an innate immune sensor, NLRP3 inflammasome is capable of detecting various detrimental stimuli, such as oxidative stress and cholesterol crystals, and subsequently inducing the secretion of potent pro-inflammatory cytokines, including IL-1β, IL-6, and IL-18, into the extracellular space, thereby promoting inflammation at the site of atherosclerotic lesions[36].
DAB2 is a versatile adapter protein that participates in a variety of cellular functions, such as endocytosis, cell signaling, lipid uptake, cholesterol homeostasis, and cell adhesion[37]. Previous study[38] have shown that the expression of DAB2 is increased in M2 macrophages of both mice and humans, while it is suppressed in M1 macrophages, which is consistent with our analytical results. DAB2 modulates macrophage polarization and inflammatory signaling by binding to κ receptor-associated factor (TRAF6) and inhibiting the NF-TRAFB pathway. After knocking out Dab2 in mouse bone marrow, the level of LDL in the serum was significantly increased, as well as the expression of systemic inflammation and cytokines, leading to liver damage. However, its role in atherosclerosis is still unclear[39, 40].
HMOX1 exhibits a protective effect against atherosclerosis. Numerous studies have demonstrated that HMOX1 not only promotes the polarization of macrophages to the M2 subtype[41], intensifying their phagocytic capability, but also inhibits pro-inflammatory responses and stimulates the secretion of IL-10[42]. Additionally, HMOX1 enables macrophages to shield the tissues from oxidative damage[43, 44].
IL1RN suppresses the functions of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and regulates multiple immune and inflammatory reactions related to interleukin 1, especially during the acute stage of infection and inflammation[45]. Its anti-inflammatory effects may play a critical role in atherosclerosis[46].
In addition, we subdivided macrophages into subpopulations and conducted a pseudo-temporal analysis to evaluate the trajectory of macrophages. M2 polarization appears to be the default choice for resident macrophages, but M2 and M1 macrophages can interconvert in response to specific environmental stimuli[47-49]. According to our analysis results, promoting the expression of STAB1 and DAB1 while inhibiting the expression of IL1RN and NLRP3 may suppress M2-to-M1 polarization and thus play a role in anti-atherosclerosis.
Although our key genes have demonstrated accurate diagnostic ability and were validated using external datasets, some limitations need to be clarified. Firstly, the establishment and validation of the model were performed on small sample public datasets; large-scale validation and determination of the optimal cutoff value are needed. Secondly, the impact of key genes on macrophage polarization requires further in vivo and in vitro experiments for validation.
In conclusion, our study has identified a gene signature consisting of STAB1, NLRP3, IL1RN, HMOX1, and DAB2 through integrative multi-omics analysis, which may play a crucial role in the development and progression of atherosclerosis.